Loading
A phase 1 trial of Sovilnesib run by Volastra Therapeutics, Inc., completed.
Study of AMG 650 in Adult Participants With Advanced Solid Tumors is a phase 1 interventional study registered as NCT04293094 by Volastra Therapeutics, Inc., with 66 participants enrolled, started 2020-03-11, primary completion reached 2022-10-24. Conditions recorded: Advanced Solid Tumors. Interventions recorded: AMG 650.
Shares Sovilnesib, Volastra Therapeutics and the tag pipeline.
Shares Volastra Therapeutics and the tag pipeline.
Shares Volastra Therapeutics and the tag pipeline.
Shares Sovilnesib, Volastra Therapeutics.
Shares Sovilnesib, Volastra Therapeutics.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/